Trials / Completed
CompletedNCT01616615
Aspirin for the Enhancement of Trophoblastic Invasion in Women With Abnormal Uterine Artery Doppler at 11-14 Weeks of Gestation
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 190 (actual)
- Sponsor
- Sara Varea · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To establish wether a prophylactic intervention from first trimester with low-dose of aspirin improves trophoblastic invasion evaluated at third trimester in women defined as high-risk by abnormal uterine artery Doppler at first trimester
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Aspirin | 150 mg/day oral use |
| DRUG | placebo | 1 capsule / day oral use |
Timeline
- Start date
- 2012-09-01
- Primary completion
- 2015-04-01
- Completion
- 2015-04-01
- First posted
- 2012-06-12
- Last updated
- 2015-08-18
Locations
3 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT01616615. Inclusion in this directory is not an endorsement.